tiprankstipranks
Zeo ScientifiX (ZEOX)
OTHER OTC:ZEOX
US Market

Zeo ScientifiX (ZEOX) Price & Analysis

53 Followers

ZEOX Stock Chart & Stats

$1.85
-$0.01(-0.37%)
At close: 4:00 PM EST
$1.85
-$0.01(-0.37%)

Zeo ScientifiX News

ZEOX FAQ

What was Zeo ScientifiX’s price range in the past 12 months?
Zeo ScientifiX lowest stock price was $1.20 and its highest was $2.99 in the past 12 months.
    What is Zeo ScientifiX’s market cap?
    Zeo ScientifiX’s market cap is $13.72M.
      When is Zeo ScientifiX’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Zeo ScientifiX’s earnings last quarter?
      Currently, no data Available
      Is Zeo ScientifiX overvalued?
      According to Wall Street analysts Zeo ScientifiX’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Zeo ScientifiX pay dividends?
        Zeo ScientifiX does not currently pay dividends.
        What is Zeo ScientifiX’s EPS estimate?
        Zeo ScientifiX’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Zeo ScientifiX have?
        Zeo ScientifiX has 7,837,441 shares outstanding.
          What happened to Zeo ScientifiX’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Zeo ScientifiX?
          Currently, no hedge funds are holding shares in ZEOX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Zeo ScientifiX

            Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
            Similar Stocks
            Company
            Price & Change
            Follow
            Imunon
            XTL Biopharmaceuticals Sponsored ADR
            Marker Therapeutics
            Dogwood Therapeutics
            AEON Biopharma

            Ownership Overview

            29.79%70.21%
            29.79% Insiders
            ― Other Institutional Investors
            70.21% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks